Sign In
Buy RLFTF
$0.246
+0.0027 (+1.12%)
At Close: Jul 31, 2026
Relief Reports Half-Year 2021 Results and Provides Corporate Update
01:20am, Friday, 24'th Sep 2021
GENEVA, SWITZERLAND / ACCESSWIRE / September 24, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief f
Relief Therapeutics' Lead Candidate Gets US Orphan Drug Tag In Sarcoidosis
06:34am, Tuesday, 03'rd Aug 2021
The FDA has granted Orphan Drug Designation to Relief Therapeutics Holding AG's (OTC: RLFTF) for RLF-100 (aviptadil), an inhaled formulation, for sarcoidosis. RLF-100 is a synthetic form of vasoac
RLFTF Stock Increases Over 29% Intraday: Why It Happened
02:34pm, Friday, 23'rd Jul 2021
The stock price of Relief Therapeutics Holding SA (OTCMKTS: RLFTF) increased by over 29% during intraday trading. This is why it happened.
RLFTF Stock Price: 10.25% Increase Explanation
08:44pm, Sunday, 23'rd May 2021
The stock price of Relief Therapeutics (OTCMKTS: RLFTF) increased by 10.25% on Friday, May 21. This is why it happened.
What Will the Stock Market Do Today? 3 Big Stories to Watch.
10:14am, Monday, 29'th Mar 2021
Good morning and welcome to the stock market today! The Ever Given is free, Wall Street is caught up in a fire sale tizzy and cryptos are climbing again.
Chinese Stocks: The Archegos Drama That Has BIDU, GSX, VIPS, TME Stocks Moving
09:26am, Monday, 29'th Mar 2021
Chinese stocks are on the move Monday morning as additional context from blocks sales last week reveals what all the hubbub is about. The post Chinese Stocks: The Archegos Drama That Has BIDU, GSX, VI
RLFTF Stock: Why Relief Therapeutics and BRPA Stock Are Soaring Today
08:36am, Monday, 29'th Mar 2021
After taking a hit in recent weeks, RLFTF stock investors got some good news on its respiratory failure treatment collaboration with BRPA target NeuroRx. The post RLFTF Stock: Why Relief Therapeutics
Relief Appoints Chris L.J.J. Stijnen as Chief Commercial Officer
01:20am, Monday, 21'st Dec 2020
GENEVA, SWITZERLAND / ACCESSWIRE / December 21, 2020 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) ("Relief" or the "Company"), a biopharmaceutical company with its lead compound RLF-100TM (
A Swiss biotech firm developing a Covid treatment has seen its share price soar 38,000% this year
02:45am, Monday, 14'th Dec 2020
Swiss biotech firm Relief Therapeutics has seen its share price climb by nearly 38,000% so far this year, as it develops a drug focused on respiratory failure arising from severe Covid-19.
RADNOR, Pa. and GENEVA, Nov. 13, 2020 /PRNewswire/ -- NeuroRx, Inc. and Relief Therapeutics Holdings AG (SIX:RLF, OTCBB:RLFTF) ("Relief") announced that as of today, 150 patients (out of a targeted en
